Literature DB >> 32783325

Histopathological evaluation of different regenerative protocols using Chitosan-based formulations for management of immature non-vital teeth with apical periodontitis: In vivo study.

Khaled Farouk Abbas1, Hossam Tawfik2, Ahmed Abdel Rahman Hashem2, Hany Mohamed Aly Ahmed3, Ashraf Mohamed Abu-Seida4, Hanan Mohamed Refai5.   

Abstract

This study aimed to assess regenerative treatment protocols for maturogenesis of immature teeth with apical periodontitis in dogs. Apical periodontitis was induced in immature premolars of 8 mongrel dogs teeth that were divided into 5 groups; regeneration via blood clotting (REG group); chitosan loaded with demineralised bone matrix (REG-CD group); chitosan loaded with dexamethazone corticosteroid (REG-CC group); and positive and negative control groups. All groups showed comparable apical hard tissue formation and significantly different from the control group. Results also showed decrease in inflammatory tissue reaction, bone resorption and periodontal ligament thickness. Tissue reaction and inflammatory infiltrates were significantly less in REG-CC group compared to others. Other parameters showed no significant difference. In conclusion, regenerative endodontic techniques using chitosan-based formulations have the potential to be used as an alternative for root maturation in teeth with apical periodontitis.
© 2020 Australian Society of Endodontology Inc.

Entities:  

Keywords:  apical periodontitis; chitosan; immature teeth; regenerative endodontic procedures

Mesh:

Substances:

Year:  2020        PMID: 32783325     DOI: 10.1111/aej.12426

Source DB:  PubMed          Journal:  Aust Endod J        ISSN: 1329-1947            Impact factor:   1.659


  1 in total

1.  The effect of changing apical foramen diameter on regenerative potential of mature teeth with necrotic pulp and apical periodontitis.

Authors:  Hisham M Abada; Ahmed Abdel Rahman Hashem; Ashraf Mohamed Abu-Seida; Mohamed Mokhtar Nagy
Journal:  Clin Oral Investig       Date:  2021-09-04       Impact factor: 3.573

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.